Nasal spray efficient way of transporting drugs with potential use in crossing the blood–brain barrier. Antihistamines work by competing for receptor sites to block the function of histamine, thereby reducing the inflammatory effect. Antihistamine nasal sprays include: Corticosteroid nasal sprays can be used to relieve the symptoms of sinusitis, hay fever, allergic rhinitis and non-allergic (perennial) rhinitis. They can reduce inflammation and histamine production in the nasal passages, and have been shown to relieve nasal congestion, runny nose, itchy nose and sneezing. Side effects may include headaches, nausea and nose bleeds. Corticosteroid nasal sprays include: Influenza vaccine is available in the form
Nasal EPAP obstruction. Side effects that emerged during clinical trials included difficulty breathing, difficulty falling or staying asleep, dry mouth, nasal congestion, headache, difficulty putting on or removing the device, and anxiety. Ventus Medical received FDA 510K clearance for marketing the Provent EPAP device for OSA in 2009. Ventus received 510K clearance for an EPAP device to treat snoring in June 2012. Ventus was acquired by Theravent Inc. in 2013. Calik MW. Treatments for Obstructive Sleep Apnea. J Clin Outcomes Manag. 2016 Apr;23(4):181-192. Nasal EPAP Nasal expiratory positive airway pressure (Nasal EPAP) is a treatment for obstructive sleep apnea (OSA) and snoring.